Home / World Marketplace / Archive by category Global Health & Biotech (Page 10)

Archive by category Global Health & Biotech

Rentschler Biopharma further expands its services in Japan and South Korea and will attend BioProcess International Asia

Members of Management and Business Development will be at BioProcess International Asia in Kyoto, Japan, October 20-22, 2025 Company will introduce the Rentschler Expression Platform for accelerated timelines in Cell Line Development and Rentschler Development Services for best-fit solutions LAUPHEIM, Germany, Oct. 06, 2025 (Korea Bizwire) – Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for [...]

FCTC’s Failure to Uphold Harm Reduction Risks Global Public Health

MANILA, Philippines, Oct. 06, 2025 (Korea Bizwire) – The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) has serious concerns over how The World Health Organization’s Framework Convention on Tobacco Control (FCTC) defines tobacco control as including harm reduction, yet the current COP11 agenda dangerously ignores this core principle. Article 1(d) explicitly identifies harm reduction [...]

Moffitt Cancer Center Selects Evident’s Pramana Technology to Expand Digital Pathology

WALTHAM, Mass., Oct. 02, 2025 (Korea Bizwire) – Moffitt Cancer Center and Evident, which recently acquired Pramana Inc., today announced a strategic partnership, leveraging the Pramana high-throughput scanning system to support digital adoption across Moffitt’s clinical and research programs. “Digital pathology is critical to advancing precision oncology,” said Karen Lu, MD, Executive Vice President and Physician-in-Chief at [...]

AAVantgarde Announces FDA Orphan Drug Designation and UK CTA approval for AAVB-039 for the Treatment of Stargardt Disease

AAVB-039 addresses the root cause of the disease, benefitting patients with any ABCA4 mutation AAVB-039 is currently being assessed in the CELESTE interventional clinical trial and we continue recruiting in our STELLA observational study MILAN, Oct. 02, 2025 (Korea Bizwire) – AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced [...]

Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty

Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its CORIOGRAPH Pre-Op Planning and Modeling Services for total shoulder arthroplasty, now available in the United States. This innovative software offers image-based planning capabilities that enable surgeons to [...]

Carestream Introduces New Software Update to Boost Diagnostic Accuracy

New Enhancements Elevate Confidence, Enhance Patient Care Rochester, N.Y., Oct. 01, 2025 (Korea Bizwire) – Carestream today announced the latest update to its Image Suite V4 Software, MR 11: a series of enhancements to help improve customer confidence and increase diagnostic accuracy while delivering a more user and patient-friendly experience. Designed to optimize imaging performance [...]

Pooled data presented at ERS: nerandomilast monotherapy linked to nominally significant reduction in risk of death in IPF and PPF

A new pooled analysis of the FIBRONEER™-IPF and FIBRONEER™-ILD trials resulted in a nominally significant reduction in the risk of death by 59% in patients who received 18mg nerandomilast without background therapy versus placebo.1 Both FIBRONEER™ phase III trials, had met their primary endpoint (reduction of lung function decline measured in forced vital capacity) but [...]

Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025

September 26, 2025 New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with advanced workflows and long-term value Philips debuts helium-free [2] BlueSeal RT 1.5T 70cm MR system with AI-powered SmartSpeed Precise, expanding its leadership in sustainable MR for radiation oncology Amsterdam, the Netherlands – At the American Society [...]

Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly

Novel nonpeptide SST2 agonist PALSONIFY advances the treatment paradigm as the first once-daily, oral therapy approved by the FDA to treat acromegaly Approval based on data from two pivotal Phase 3 trials where PALSONIFY was well tolerated and resulted in rapid, durable, and consistent biochemical control and reduced symptom burden Launch of lead product PALSONIFY [...]

Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025

TEL AVIV, Israel, Sept. 25, 2025 (Korea Bizwire) – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2025 financial results on Wednesday, November 5, 2025, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on [...]